BDRX
Price
$1.27
Change
+$0.01 (+0.79%)
Updated
Aug 21 closing price
Capitalization
1.31M
Intraday BUY SELL Signals
GPCR
Price
$49.09
Change
-$1.43 (-2.83%)
Updated
Aug 21 closing price
Capitalization
3.5B
87 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDRX vs GPCR

BDRX vs GPCR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BDRX vs. GPCR commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDRX is a Hold and GPCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (BDRX: $1.27 vs. GPCR: $49.09)
Brand notoriety: BDRX and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDRX: 19% vs. GPCR: 76%
Market capitalization -- BDRX: $1.31M vs. GPCR: $3.5B
BDRX [@Biotechnology] is valued at $1.31M. GPCR’s [@Biotechnology] market capitalization is $3.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDRX’s FA Score shows that 0 FA rating(s) are green whileGPCR’s FA Score has 1 green FA rating(s).

  • BDRX’s FA Score: 0 green, 5 red.
  • GPCR’s FA Score: 1 green, 4 red.
According to our system of comparison, GPCR is a better buy in the long-term than BDRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDRX’s TA Score shows that 5 TA indicator(s) are bullish while GPCR’s TA Score has 3 bullish TA indicator(s).

  • BDRX’s TA Score: 5 bullish, 3 bearish.
  • GPCR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BDRX is a better buy in the short-term than GPCR.

Price Growth

BDRX (@Biotechnology) experienced а -16.45% price change this week, while GPCR (@Biotechnology) price change was -9.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

GPCR is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($3.5B) has a higher market cap than BDRX($1.31M). GPCR YTD gains are higher at: -29.418 vs. BDRX (-88.811). BDRX has higher annual earnings (EBITDA): -6.07M vs. GPCR (-218.24M). BDRX (0) and GPCR (0) have equivalent revenues.
BDRXGPCRBDRX / GPCR
Capitalization1.31M3.5B0%
EBITDA-6.07M-218.24M3%
Gain YTD-88.811-29.418302%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A1.46B-
Total DebtN/A5.79M-
FUNDAMENTALS RATINGS
BDRX: Fundamental Ratings
BDRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDRXGPCR
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 19 days ago
75%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BDRX
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IVLU44.460.52
+1.18%
iShares Edge MSCI Intl Value Factor ETF
SDTY41.290.17
+0.42%
YieldMax S&P 500 0DTE Cov Cll Stgy ETF
NUSB25.24N/A
+0.02%
Nuveen Ultra Short Income ETF
FLYD41.57N/A
N/A
MicroSectors™ Travel -3X Inv Lvgd ETNs
IBTM22.42-0.04
-0.18%
iShares iBonds Dec 2032 Term Trs ETF

BDRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been loosely correlated with SNTI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BDRX jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
+0.79%
SNTI - BDRX
34%
Loosely correlated
-10.87%
GPCR - BDRX
33%
Poorly correlated
-2.83%
SCNI - BDRX
32%
Poorly correlated
-89.05%
PRQR - BDRX
32%
Poorly correlated
+3.08%
KRRO - BDRX
32%
Poorly correlated
+1.70%
More

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with WVE. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
-2.83%
WVE - GPCR
65%
Loosely correlated
+0.76%
KYMR - GPCR
62%
Loosely correlated
-1.40%
NRIX - GPCR
46%
Loosely correlated
-1.22%
OCUL - GPCR
45%
Loosely correlated
-0.09%
FULC - GPCR
41%
Loosely correlated
-0.52%
More